Acta Physiologica Scandinavica · 1988 · 30 citations · 20 references
MedicineNeurosciencePharmacologyNeuropharmacologyPharmacodynamicsPsychopharmacologyAntipsychotic PharmacologyDopaminergic PharmacologyDopaminergic SignalingMonoamine NeurochemistryNeuromodulationNeurotransmitter SystemsD1-like Dopamine ReceptorsDopamine D1-like ReceptorsDopamine D2-like ReceptorsDopamine PharmacodynamicsDopamine Receptor AgonistsDopamine Receptor SubtypesDopaminergic ModulationDopaminergic Pathways
Possible postsynaptic effects of the preferential dopamine autoreceptor agonist B-HT 920 were studied by means of the mouse motor activity. In reserpine-treated mice, B-HT 920 did not cause any motor activity by itself but it markedly potentiated the slight stimulating effect of the D1 dopamine agonist SKF 38 393. The effect was blocked by either the D2-receptor antagonist sulpiride or the D1-receptor antagonist SCH 23 390, indicating that motor activity is dependent on simultaneous activation of both dopamine receptor types. The hyperactivity produced by 0.1 mg kg-1 B-HT 920 in combination with SKF 38 393 in reserpine-treated mice was at least as great as that following a maximal dose of apomorphine, indicating that B-HT 920 is a full agonist at postsynaptic D2 receptors. The effect of 0.1 mg kg-1 B-HT 920 peaked earlier than those of 1 mg kg-1 and particularly, 10 mg kg-1 suggesting additional effects of the later two doses. B-HT 920 stimulates dopamine autoreceptors almost maximally following 0.1 or 1 mg kg-1 but only the latter dose (with or without SKF 38 393) caused hyperactivity of mice not treated with reserpine. This finding indicates that the postsynaptic D2 receptors are less sensitive to B-HT 920 than the D2 dopamine autoreceptors.
20
Statistical Principles in Experimental Design
Paul E. Green, B. J. WINER, Donald R. Brown et al. · Journal of Marketing Research · 1992 · 4.4K citations
SCH 23390—The first selective dopamine D-1 antagonist
John Hyttel · European Journal of Pharmacology · 1983 · 739 citations
Medicine, Neuroscience, Pharmacology +13
The central effects of a novel dopamine agonist
Paulette E. Setler, Henry M. Sarau, Charles L. Zirkle et al. · European Journal of Pharmacology · 1978 · 643 citations
Medicine, Neuroscience, Pharmacology +14